Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV
Authors:
- Gayle SpringerGSGayle Springer
- Lisa JacobsonLJLisa Jacobson
- Heather WattsHWHeather Watts
- Kathryn AnastosKAKathryn Anastos
- Abner KornAKAbner Korn
- Helen CejtinHCHelen Cejtin
- Alice StekASAlice Stek
- Mary YoungMYMary Young
- Julie SchmidtJSJulie Schmidt
- Howard MinkoffHMHoward Minkoff
- 1 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (2) , 281-286
Abstract
To determine frequency and outcomes of pregnancy in US women with HIV before and after introduction of highly active antiretroviral therapy (HAART). Prospective cohort study at six US centers. HIV seropositive and at-risk seronegative women reported pregnancy outcomes at 6-month intervals during the period 1 October 1994 to 31 March 2002. Outcomes were tabulated and pregnancy rates calculated. Logistic regression defined outcome correlates. Pregnancy rates were 7.4 and 15.2 per 100 person-years in seropositive and seronegative women, respectively (P < 0.0001). Among seropositives, 119 (36%) pregnancies ended in live birth, six (2%) in stillbirth, 126 (36%) in abortion, 83 (24%) in miscarriage, 16 (5%) in ectopic pregnancy, and two (1%) in other outcomes (P = nonsignificant versus seronegatives). Independent baseline correlates of conception in seropositives included younger age [odds ratio (OR), 1.20; 95% confidence interval (CI), 1.16–1.23], prior abortion (OR, 1.79; 95% CI, 1.25–2.63), lower HIV RNA levels (OR, 1.30; 95% CI, 1.10–1.54 for each log decrease), and being unmarried (OR, 1.59; 95% CI, 1.02–2.44). Baseline antiretroviral use at baseline was linked to lower conception risk (OR, 0.34; 95% CI, 0.49–0.98 for mono- or combination therapy; OR, 0.34; 95% CI, 0.03–4.28 for HAART). Abortion was less likely during the HAART era, (OR, 0.68; 95% CI, 0.35–1.33 during the early HAART era; OR, 0.46; 95% CI, 0.23–0.90 during the later HAART era, compared with before HAART). Women with HIV were less likely to conceive than at-risk uninfected women, but pregnancy outcomes were similar. Abortion became less common after the introduction of HAART.Keywords
This publication has 20 references indexed in Scilit:
- Changing trends in pregnancy outcome among HIV-infected women between 1985 and 1997 in two southern French university hospitalsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- Management of Human Immunodeficiency Virus Infection in PregnancyNew England Journal of Medicine, 2002
- The relationship of pregnancy to the use of highly active antiretroviral therapyAmerican Journal of Obstetrics and Gynecology, 2001
- Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected womenAIDS, 2000
- The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women‚s interagency HIV studyAIDS, 1999
- Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women‚s Interagency HIV StudyAIDS, 1999
- Sexual Behavior and Pregnancy Outcome in HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Pregnancy rates among women infected with human immunodeficiency virusObstetrics & Gynecology, 1996
- Factors associated with pregnancy and pregnancy resolution in HIV seropositive womenSocial Science & Medicine, 1995
- Women's knowledge of their HIV antibody state: its effect on their decision whether to continue the pregnancy.BMJ, 1990